Day Traders Diary
5/29/14U.S. equity futures hold slim gains amid quiet action overseas. The S&P 500 futures hover almost four points above fair value.
Reviewing overnight developments:
Asian markets ended mixed. Japan's Nikkei +0.1%, Hong Kong's Hang Seng -0.3%, and China's Shanghai Composite -0.5%.
In economic data:
Japan's Retail Sales fell 4.4% year-over-year (expected -3.3%, previous 11.0%).
Australia's Private New Capital Expenditure fell 4.2% quarter-over-quarter (consensus -1.4%, previous -4.5%), while HIA New Home Sales rose 2.9% month-over-month (prior 0.2%).
Bank of Japan member Sayuri Shirai said she remains confident in the central bank's ability to reach its inflation target, but that achieving the goal could take more than two years.
Major European indices trade mostly lower. Great Britain's FTSE +0.3%, Germany's DAX -0.1%, and France's CAC -0.1%. Elsewhere, Italy's MIB -0.4% and Spain's IBEX -0.3%.
Economic data was limited:
Spain's GDP rose 0.4% quarter-over-quarter, as expected.
Among news of note:
Even though the major markets are open in Europe, participation has been limited due to Ascension Day closures in Austria, Norway, and Switzerland, among others.
In U.S. corporate news:
Costco (COST 113.49, -0.75): -0.7% following its earnings miss on below-consensus revenue; however, the company surpassed its Q3 comparable store sales guidance.
Palo Alto Networks (PANW 78.50, +8.99): +12.9% after beating the Capital IQ consensus estimate by one cent on above-consensus revenue.
ReneSola (SOL 2.40, -0.30): -11.1% after reporting below-consensus earnings and revenue.
Weekly initial claims (Briefing.com consensus 318,000) and the second estimate of Q1 GDP (consensus -0.5%) will be reported at 8:30 ET, while the Pending Home Sales report for April (consensus 1.0%) will be released at 10:00 ET. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.